Bristol-Myers Squibb
In Chris Begg's portfolio · East Coast Asset Management
Ticker BMY
Not in the portfolio as of Q3 2026. Every quarter it shows up in a East Coast Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2016 | Sell | 0 | |
| Q1 2016 | No change | 31,780 | 1.1% |
| Q4 2015 | No change | 31,780 | 1.2% |
| Q3 2015 | No change | 31,780 | 1.2% |
| Q2 2015 | No change | 31,780 | 1.1% |
| Q1 2015 | Add 1% | 31,780 | 1.1% |
| Q4 2014 | No change | 31,458 | 1.0% |
| Q3 2014 | No change | 31,458 | 0.9% |
| Q2 2014 | No change | 31,458 | 0.8% |
| Q1 2014 | No change | 31,458 | 0.9% |
| Q4 2013 | No change | 31,457 | 1.0% |
| Q3 2013 | Add 3% | 31,457 | 1.0% |
| Q2 2013 | No change | 30,596 | 0.7% |
| Q1 2013 | No change | 30,595 | 0.8% |
| Q4 2012 | First 13F | 30,595 | 0.7% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.